

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 4.92733428 |
| 2 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.45915122 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 4.17096601 |
| 4 | cell communication involved in cardiac conduction (GO:0086065) | 4.08996570 |
| 5 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.07122280 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.02936320 |
| 7 | sensory perception of smell (GO:0007608) | 3.92894296 |
| 8 | actin-mediated cell contraction (GO:0070252) | 3.78710095 |
| 9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.77327270 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.74930377 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.71526063 |
| 12 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.62421952 |
| 13 | vocalization behavior (GO:0071625) | 3.62375616 |
| 14 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.57856554 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.48894154 |
| 16 | cardiac conduction (GO:0061337) | 3.45720229 |
| 17 | skeletal muscle contraction (GO:0003009) | 3.45576189 |
| 18 | fatty acid transmembrane transport (GO:1902001) | 3.44319210 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 3.38220829 |
| 20 | behavioral response to nicotine (GO:0035095) | 3.35234681 |
| 21 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.34514305 |
| 22 | detection of calcium ion (GO:0005513) | 3.34481133 |
| 23 | glutamate secretion (GO:0014047) | 3.32656526 |
| 24 | cardiac muscle contraction (GO:0060048) | 3.31387032 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.29694860 |
| 26 | cardiac myofibril assembly (GO:0055003) | 3.28796293 |
| 27 | cell communication by electrical coupling (GO:0010644) | 3.27670970 |
| 28 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.22048520 |
| 29 | regulation of cell communication by electrical coupling (GO:0010649) | 3.16960454 |
| 30 | cardiac muscle cell action potential (GO:0086001) | 3.15373282 |
| 31 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.14343663 |
| 32 | response to muscle activity (GO:0014850) | 3.12526932 |
| 33 | cardiac muscle hypertrophy (GO:0003300) | 3.08157124 |
| 34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.05928569 |
| 35 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.04455445 |
| 36 | otic vesicle formation (GO:0030916) | 3.04407978 |
| 37 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.04153076 |
| 38 | regulation of membrane repolarization (GO:0060306) | 3.03951343 |
| 39 | carnitine transmembrane transport (GO:1902603) | 3.03335746 |
| 40 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.02580187 |
| 41 | drug catabolic process (GO:0042737) | 3.00760747 |
| 42 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.00491973 |
| 43 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.95179630 |
| 44 | striated muscle hypertrophy (GO:0014897) | 2.95041114 |
| 45 | skeletal muscle adaptation (GO:0043501) | 2.94545117 |
| 46 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.93926996 |
| 47 | oxidative demethylation (GO:0070989) | 2.93586695 |
| 48 | carnitine transport (GO:0015879) | 2.91763357 |
| 49 | amino-acid betaine transport (GO:0015838) | 2.91763357 |
| 50 | interkinetic nuclear migration (GO:0022027) | 2.91274275 |
| 51 | chemosensory behavior (GO:0007635) | 2.89057393 |
| 52 | myotube cell development (GO:0014904) | 2.87521812 |
| 53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.86501290 |
| 54 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.86453838 |
| 55 | synaptic vesicle exocytosis (GO:0016079) | 2.84944168 |
| 56 | exogenous drug catabolic process (GO:0042738) | 2.82439397 |
| 57 | sarcomere organization (GO:0045214) | 2.82241250 |
| 58 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.80642563 |
| 59 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.80394705 |
| 60 | plasma membrane repair (GO:0001778) | 2.80256127 |
| 61 | myofibril assembly (GO:0030239) | 2.77350294 |
| 62 | neuron recognition (GO:0008038) | 2.77286121 |
| 63 | regulation of hippo signaling (GO:0035330) | 2.76954945 |
| 64 | protein localization to synapse (GO:0035418) | 2.76396279 |
| 65 | positive regulation of fatty acid oxidation (GO:0046321) | 2.75696660 |
| 66 | muscle fiber development (GO:0048747) | 2.74913760 |
| 67 | skeletal muscle fiber development (GO:0048741) | 2.74859369 |
| 68 | multicellular organismal signaling (GO:0035637) | 2.74093480 |
| 69 | regulation of acrosome reaction (GO:0060046) | 2.72404418 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 2.71581486 |
| 71 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.70559067 |
| 72 | actomyosin structure organization (GO:0031032) | 2.70140544 |
| 73 | axonal fasciculation (GO:0007413) | 2.70077082 |
| 74 | relaxation of cardiac muscle (GO:0055119) | 2.70041241 |
| 75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.69888760 |
| 76 | kynurenine metabolic process (GO:0070189) | 2.69342301 |
| 77 | quaternary ammonium group transport (GO:0015697) | 2.68802140 |
| 78 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.68288192 |
| 79 | tryptophan catabolic process (GO:0006569) | 2.67785186 |
| 80 | indole-containing compound catabolic process (GO:0042436) | 2.67785186 |
| 81 | indolalkylamine catabolic process (GO:0046218) | 2.67785186 |
| 82 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.66735591 |
| 83 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.66071325 |
| 84 | dendritic spine morphogenesis (GO:0060997) | 2.65642320 |
| 85 | response to inactivity (GO:0014854) | 2.65199725 |
| 86 | actin filament-based movement (GO:0030048) | 2.64454156 |
| 87 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.64153012 |
| 88 | intestinal cholesterol absorption (GO:0030299) | 2.63860828 |
| 89 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.63451858 |
| 90 | striated muscle contraction (GO:0006941) | 2.62687046 |
| 91 | membrane repolarization during action potential (GO:0086011) | 2.62637699 |
| 92 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.61421332 |
| 93 | aromatic amino acid family catabolic process (GO:0009074) | 2.60934619 |
| 94 | regulation of synapse structural plasticity (GO:0051823) | 2.57260651 |
| 95 | muscle cell fate commitment (GO:0042693) | 2.57126175 |
| 96 | locomotory exploration behavior (GO:0035641) | 2.56576367 |
| 97 | membrane depolarization during action potential (GO:0086010) | 2.56477680 |
| 98 | gamma-aminobutyric acid transport (GO:0015812) | 2.55541375 |
| 99 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.54986715 |
| 100 | regulation of sarcomere organization (GO:0060297) | 2.54973922 |
| 101 | ketone body metabolic process (GO:1902224) | 2.54232634 |
| 102 | regulation of the force of heart contraction (GO:0002026) | 2.53405502 |
| 103 | negative regulation of protein localization to cell surface (GO:2000009) | 2.53155422 |
| 104 | regulation of heart rate (GO:0002027) | 2.53100812 |
| 105 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.53004004 |
| 106 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.52292160 |
| 107 | muscle contraction (GO:0006936) | 2.52125524 |
| 108 | reflex (GO:0060004) | 2.51305956 |
| 109 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.50514243 |
| 110 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.50429426 |
| 111 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50420754 |
| 112 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.50217888 |
| 113 | muscle hypertrophy in response to stress (GO:0003299) | 2.50217888 |
| 114 | cardiac muscle adaptation (GO:0014887) | 2.50217888 |
| 115 | carnitine shuttle (GO:0006853) | 2.50017421 |
| 116 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.49840904 |
| 117 | regulation of glucokinase activity (GO:0033131) | 2.49834278 |
| 118 | regulation of hexokinase activity (GO:1903299) | 2.49834278 |
| 119 | muscle hypertrophy (GO:0014896) | 2.49712097 |
| 120 | pharyngeal system development (GO:0060037) | 2.48458042 |
| 121 | layer formation in cerebral cortex (GO:0021819) | 2.46421791 |
| 122 | actin-myosin filament sliding (GO:0033275) | 2.46254485 |
| 123 | muscle filament sliding (GO:0030049) | 2.46254485 |
| 124 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.46203039 |
| 125 | neurotransmitter secretion (GO:0007269) | 2.45604522 |
| 126 | striated muscle atrophy (GO:0014891) | 2.44555277 |
| 127 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.44440900 |
| 128 | neuromuscular synaptic transmission (GO:0007274) | 2.43511493 |
| 129 | female mating behavior (GO:0060180) | 2.42138178 |
| 130 | exploration behavior (GO:0035640) | 2.41780580 |
| 131 | regulation of female receptivity (GO:0045924) | 2.41678485 |
| 132 | epithelial cell maturation (GO:0002070) | 2.41568488 |
| 133 | neuronal action potential propagation (GO:0019227) | 2.41036582 |
| 134 | regulation of relaxation of muscle (GO:1901077) | 2.40562714 |
| 135 | regulation of actin filament-based movement (GO:1903115) | 2.40385406 |
| 136 | regulation of striated muscle contraction (GO:0006942) | 2.39721793 |
| 137 | nucleobase catabolic process (GO:0046113) | 2.38947895 |
| 138 | L-phenylalanine catabolic process (GO:0006559) | 2.38469758 |
| 139 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.38469758 |
| 140 | synaptic transmission, glutamatergic (GO:0035249) | 2.37227275 |
| 141 | regulation of action potential (GO:0098900) | 2.36823894 |
| 142 | regulation of fatty acid oxidation (GO:0046320) | 2.36541131 |
| 143 | indolalkylamine metabolic process (GO:0006586) | 2.35975776 |
| 144 | striated muscle adaptation (GO:0014888) | 2.35866586 |
| 145 | muscle system process (GO:0003012) | 2.35838302 |
| 146 | adult heart development (GO:0007512) | 2.35320776 |
| 147 | positive regulation of glycolytic process (GO:0045821) | 2.34982944 |
| 148 | action potential (GO:0001508) | 2.34689894 |
| 149 | * glutamate receptor signaling pathway (GO:0007215) | 2.34126215 |
| 150 | myoblast fusion (GO:0007520) | 2.34038690 |
| 151 | cell migration in hindbrain (GO:0021535) | 2.33189408 |
| 152 | detection of light stimulus involved in visual perception (GO:0050908) | 2.32901291 |
| 153 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.32901291 |
| 154 | positive regulation of synapse maturation (GO:0090129) | 2.32675286 |
| 155 | serotonin metabolic process (GO:0042428) | 2.32591900 |
| 156 | short-chain fatty acid metabolic process (GO:0046459) | 2.32375802 |
| 157 | positive regulation of cation channel activity (GO:2001259) | 2.31646066 |
| 158 | regulation of sequestering of triglyceride (GO:0010889) | 2.31563785 |
| 159 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.30823502 |
| 160 | myotube differentiation (GO:0014902) | 2.30569150 |
| 161 | calcium ion import (GO:0070509) | 2.29642325 |
| 162 | L-phenylalanine metabolic process (GO:0006558) | 2.29328878 |
| 163 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.29328878 |
| 164 | glyoxylate metabolic process (GO:0046487) | 2.28356408 |
| 165 | response to caffeine (GO:0031000) | 2.23732319 |
| 166 | primary amino compound metabolic process (GO:1901160) | 2.23581873 |
| 167 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.23578725 |
| 168 | biotin metabolic process (GO:0006768) | 2.22101662 |
| 169 | righting reflex (GO:0060013) | 2.21897747 |
| 170 | piRNA metabolic process (GO:0034587) | 2.21847322 |
| 171 | tryptophan metabolic process (GO:0006568) | 2.21606801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.57477356 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.09034987 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.67671325 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42252462 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.39677412 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32051944 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25544542 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21744369 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21744369 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.17443906 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.13127084 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07887306 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07787149 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.04677859 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.04407097 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.03523921 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95338629 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.92953576 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92284917 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90828854 |
| 21 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.89258622 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84001578 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77564538 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74905799 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74200315 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71864188 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69951817 |
| 28 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.67169302 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53405687 |
| 30 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51862803 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49530453 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.48652544 |
| 33 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47770807 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47770807 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46803441 |
| 36 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.46539299 |
| 37 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45042024 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44803036 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43657149 |
| 40 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.43247169 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42885132 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42833337 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42452548 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42281331 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.40371051 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39219236 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38625763 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37854440 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36499833 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36492468 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35847731 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33968698 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32975273 |
| 54 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32556665 |
| 55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31833625 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31097039 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30594349 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30037320 |
| 59 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29695394 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29637681 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28939180 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28898285 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28438786 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28196268 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28076905 |
| 66 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26739963 |
| 67 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.26095282 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25985717 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25972625 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25744800 |
| 71 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25081169 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24338721 |
| 73 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23221478 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20092774 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19449361 |
| 76 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18690383 |
| 77 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17769588 |
| 78 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16152052 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15435331 |
| 80 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14476427 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14110595 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.13864263 |
| 83 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13853775 |
| 84 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13130038 |
| 85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10731214 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10389703 |
| 87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09912147 |
| 88 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08910473 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08883639 |
| 90 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08455497 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08434476 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08112572 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07753383 |
| 94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07511122 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07226525 |
| 96 | AR_19668381_ChIP-Seq_PC3_Human | 1.06992248 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05520901 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05520901 |
| 99 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04467762 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03143413 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03022572 |
| 102 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01943300 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01898844 |
| 104 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01898812 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00947370 |
| 106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00663508 |
| 107 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99396876 |
| 108 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98954011 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98801829 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98563637 |
| 111 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.98212358 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98209489 |
| 113 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97980100 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97190266 |
| 115 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96946244 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95706159 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94598863 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93726879 |
| 119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93581704 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92190498 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91167987 |
| 122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90893694 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90367937 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88983688 |
| 125 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88636512 |
| 126 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87873462 |
| 127 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87654741 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87527406 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86435893 |
| 130 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86418455 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86022610 |
| 132 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85903764 |
| 133 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85724609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 3.66906440 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.64367431 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.50880719 |
| 4 | MP0003880_abnormal_central_pattern | 2.83744578 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.50358668 |
| 6 | MP0004215_abnormal_myocardial_fiber | 2.44882094 |
| 7 | MP0000751_myopathy | 2.44233978 |
| 8 | MP0004270_analgesia | 2.37232340 |
| 9 | MP0003646_muscle_fatigue | 2.33516964 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.32642948 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.31872829 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.21695054 |
| 13 | MP0005365_abnormal_bile_salt | 2.18042997 |
| 14 | MP0005360_urolithiasis | 2.12560618 |
| 15 | MP0002796_impaired_skin_barrier | 1.97990486 |
| 16 | MP0004084_abnormal_cardiac_muscle | 1.95703141 |
| 17 | MP0003941_abnormal_skin_development | 1.91299228 |
| 18 | * MP0002063_abnormal_learning/memory/cond | 1.90431692 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 1.83218175 |
| 20 | MP0001968_abnormal_touch/_nociception | 1.82393006 |
| 21 | MP0003195_calcinosis | 1.80475683 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.77501797 |
| 23 | MP0004043_abnormal_pH_regulation | 1.76843849 |
| 24 | * MP0009745_abnormal_behavioral_response | 1.75293089 |
| 25 | MP0005083_abnormal_biliary_tract | 1.74518205 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.73364859 |
| 27 | MP0004484_altered_response_of | 1.68520054 |
| 28 | MP0005451_abnormal_body_composition | 1.67924699 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.67497806 |
| 30 | MP0005670_abnormal_white_adipose | 1.66362531 |
| 31 | MP0005330_cardiomyopathy | 1.65057277 |
| 32 | MP0003137_abnormal_impulse_conducting | 1.64353837 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.64283377 |
| 34 | MP0005499_abnormal_olfactory_system | 1.60807254 |
| 35 | MP0005394_taste/olfaction_phenotype | 1.60807254 |
| 36 | MP0008789_abnormal_olfactory_epithelium | 1.60363288 |
| 37 | MP0003011_delayed_dark_adaptation | 1.59902873 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.58811268 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.55287248 |
| 40 | MP0002184_abnormal_innervation | 1.55226081 |
| 41 | MP0004085_abnormal_heartbeat | 1.54535872 |
| 42 | MP0001486_abnormal_startle_reflex | 1.54006662 |
| 43 | MP0002064_seizures | 1.52244939 |
| 44 | MP0002736_abnormal_nociception_after | 1.51731647 |
| 45 | MP0002822_catalepsy | 1.50911263 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.50662281 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.49656168 |
| 48 | MP0002972_abnormal_cardiac_muscle | 1.46752700 |
| 49 | MP0000749_muscle_degeneration | 1.44337437 |
| 50 | MP0005620_abnormal_muscle_contractility | 1.43430921 |
| 51 | MP0002272_abnormal_nervous_system | 1.43183140 |
| 52 | MP0002160_abnormal_reproductive_system | 1.39877023 |
| 53 | MP0000778_abnormal_nervous_system | 1.38796095 |
| 54 | MP0005187_abnormal_penis_morphology | 1.35924186 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.35256081 |
| 56 | MP0009046_muscle_twitch | 1.32653233 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.31619482 |
| 58 | MP0000383_abnormal_hair_follicle | 1.28436063 |
| 59 | MP0004858_abnormal_nervous_system | 1.27486039 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.26328938 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.23196898 |
| 62 | MP0002108_abnormal_muscle_morphology | 1.18142677 |
| 63 | MP0005423_abnormal_somatic_nervous | 1.16942498 |
| 64 | MP0008775_abnormal_heart_ventricle | 1.15999512 |
| 65 | MP0000759_abnormal_skeletal_muscle | 1.15987648 |
| 66 | MP0004087_abnormal_muscle_fiber | 1.15132874 |
| 67 | MP0004130_abnormal_muscle_cell | 1.13773758 |
| 68 | MP0002067_abnormal_sensory_capabilities | 1.13540866 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.11330886 |
| 70 | MP0001661_extended_life_span | 1.11237677 |
| 71 | MP0001440_abnormal_grooming_behavior | 1.08304411 |
| 72 | MP0002638_abnormal_pupillary_reflex | 1.06975562 |
| 73 | MP0010678_abnormal_skin_adnexa | 1.06361940 |
| 74 | MP0003879_abnormal_hair_cell | 1.05541051 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.04258335 |
| 76 | MP0003868_abnormal_feces_composition | 1.04062631 |
| 77 | MP0000579_abnormal_nail_morphology | 1.03783252 |
| 78 | MP0000537_abnormal_urethra_morphology | 1.03533263 |
| 79 | MP0000750_abnormal_muscle_regeneration | 1.01920975 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 1.01377794 |
| 81 | MP0003252_abnormal_bile_duct | 1.01205055 |
| 82 | MP0001501_abnormal_sleep_pattern | 1.01168820 |
| 83 | MP0004233_abnormal_muscle_weight | 1.00935437 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.99799153 |
| 85 | MP0004885_abnormal_endolymph | 0.97814653 |
| 86 | MP0000733_abnormal_muscle_development | 0.96607854 |
| 87 | MP0001970_abnormal_pain_threshold | 0.96386706 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.95973314 |
| 89 | MP0002733_abnormal_thermal_nociception | 0.95820020 |
| 90 | MP0003136_yellow_coat_color | 0.95612228 |
| 91 | MP0003890_abnormal_embryonic-extraembry | 0.95605785 |
| 92 | MP0002106_abnormal_muscle_physiology | 0.95513160 |
| 93 | MP0000566_synostosis | 0.94620384 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.93860097 |
| 95 | MP0006138_congestive_heart_failure | 0.93466677 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.93454966 |
| 97 | MP0002909_abnormal_adrenal_gland | 0.90230585 |
| 98 | MP0004924_abnormal_behavior | 0.90068349 |
| 99 | MP0005386_behavior/neurological_phenoty | 0.90068349 |
| 100 | MP0008872_abnormal_physiological_respon | 0.89921109 |
| 101 | MP0005647_abnormal_sex_gland | 0.89897541 |
| 102 | MP0001544_abnormal_cardiovascular_syste | 0.89687373 |
| 103 | MP0005385_cardiovascular_system_phenoty | 0.89687373 |
| 104 | MP0004134_abnormal_chest_morphology | 0.88845872 |
| 105 | MP0003329_amyloid_beta_deposits | 0.86550256 |
| 106 | MP0004381_abnormal_hair_follicle | 0.85470308 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.85442317 |
| 108 | MP0002102_abnormal_ear_morphology | 0.85238560 |
| 109 | MP0002882_abnormal_neuron_morphology | 0.84980668 |
| 110 | MP0004811_abnormal_neuron_physiology | 0.84747631 |
| 111 | MP0005410_abnormal_fertilization | 0.83897218 |
| 112 | MP0005332_abnormal_amino_acid | 0.81049937 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.80096797 |
| 114 | MP0005646_abnormal_pituitary_gland | 0.79901144 |
| 115 | MP0003718_maternal_effect | 0.78441371 |
| 116 | MP0000538_abnormal_urinary_bladder | 0.77024785 |
| 117 | MP0000747_muscle_weakness | 0.76717069 |
| 118 | MP0005369_muscle_phenotype | 0.76706079 |
| 119 | MP0002269_muscular_atrophy | 0.76657214 |
| 120 | MP0005501_abnormal_skin_physiology | 0.74802301 |
| 121 | MP0001188_hyperpigmentation | 0.74353416 |
| 122 | MP0005266_abnormal_metabolism | 0.74242244 |
| 123 | MP0000955_abnormal_spinal_cord | 0.73190182 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.72615148 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.72504620 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.72423301 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.71926412 |
| 128 | MP0002127_abnormal_cardiovascular_syste | 0.71900829 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.71639531 |
| 130 | MP0001664_abnormal_digestion | 0.71405803 |
| 131 | MP0005535_abnormal_body_temperature | 0.71034281 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.71013520 |
| 133 | MP0002066_abnormal_motor_capabilities/c | 0.70935271 |
| 134 | MP0010630_abnormal_cardiac_muscle | 0.70011882 |
| 135 | MP0003878_abnormal_ear_physiology | 0.69009081 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.69009081 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.68802196 |
| 138 | MP0004142_abnormal_muscle_tone | 0.68316424 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.68109832 |
| 140 | MP0000427_abnormal_hair_cycle | 0.65258079 |
| 141 | MP0004510_myositis | 0.65193978 |
| 142 | MP0001346_abnormal_lacrimal_gland | 0.64643917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.00062195 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.72569941 |
| 3 | Nemaline bodies (HP:0003798) | 5.67135575 |
| 4 | Sudden death (HP:0001699) | 5.55090981 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 4.96344111 |
| 6 | Syncope (HP:0001279) | 4.65482278 |
| 7 | Focal motor seizures (HP:0011153) | 4.19534956 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.13126923 |
| 9 | Ventricular fibrillation (HP:0001663) | 4.05052186 |
| 10 | Ventricular tachycardia (HP:0004756) | 3.89068603 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.85142724 |
| 12 | Atrial fibrillation (HP:0005110) | 3.71784198 |
| 13 | Primary atrial arrhythmia (HP:0001692) | 3.63795161 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.63383751 |
| 15 | Supraventricular tachycardia (HP:0004755) | 3.44412104 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 3.43028672 |
| 17 | Prolonged QT interval (HP:0001657) | 3.38376967 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 3.32282077 |
| 19 | Palpitations (HP:0001962) | 3.31213082 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 3.30129093 |
| 21 | Ventricular arrhythmia (HP:0004308) | 3.22568869 |
| 22 | Febrile seizures (HP:0002373) | 3.22065687 |
| 23 | Focal seizures (HP:0007359) | 3.20806317 |
| 24 | Atonic seizures (HP:0010819) | 3.14643330 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 3.13057043 |
| 26 | Myokymia (HP:0002411) | 3.11070439 |
| 27 | Hyperventilation (HP:0002883) | 3.09061468 |
| 28 | Distal arthrogryposis (HP:0005684) | 2.95943304 |
| 29 | Absence seizures (HP:0002121) | 2.91914476 |
| 30 | Hyperkalemia (HP:0002153) | 2.85552053 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.78822758 |
| 32 | Visual hallucinations (HP:0002367) | 2.75111884 |
| 33 | Abnormal EKG (HP:0003115) | 2.71989808 |
| 34 | Bundle branch block (HP:0011710) | 2.71625302 |
| 35 | Pancreatic cysts (HP:0001737) | 2.61786209 |
| 36 | Lip pit (HP:0100267) | 2.55378914 |
| 37 | Dialeptic seizures (HP:0011146) | 2.55258027 |
| 38 | Popliteal pterygium (HP:0009756) | 2.53973759 |
| 39 | Hyperglycinemia (HP:0002154) | 2.49848672 |
| 40 | Ketosis (HP:0001946) | 2.47428773 |
| 41 | Myopathic facies (HP:0002058) | 2.45507039 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.42443135 |
| 43 | Frequent falls (HP:0002359) | 2.41354919 |
| 44 | Epileptic encephalopathy (HP:0200134) | 2.41205945 |
| 45 | Ketoacidosis (HP:0001993) | 2.39388891 |
| 46 | Cerebral edema (HP:0002181) | 2.39298864 |
| 47 | Acute encephalopathy (HP:0006846) | 2.35600605 |
| 48 | Absent phalangeal crease (HP:0006109) | 2.30272369 |
| 49 | Heart block (HP:0012722) | 2.30253767 |
| 50 | Exercise-induced muscle cramps (HP:0003710) | 2.30187047 |
| 51 | Progressive cerebellar ataxia (HP:0002073) | 2.28986500 |
| 52 | Lipoatrophy (HP:0100578) | 2.28286210 |
| 53 | EMG: myopathic abnormalities (HP:0003458) | 2.27476411 |
| 54 | Anosmia (HP:0000458) | 2.26516891 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.26191434 |
| 56 | Progressive macrocephaly (HP:0004481) | 2.26167129 |
| 57 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.24513835 |
| 58 | Conjunctival hamartoma (HP:0100780) | 2.20545768 |
| 59 | Fetal akinesia sequence (HP:0001989) | 2.16309425 |
| 60 | Abnormal atrioventricular conduction (HP:0005150) | 2.16179090 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.15414237 |
| 62 | Palmoplantar keratoderma (HP:0000982) | 2.14364543 |
| 63 | Double outlet right ventricle (HP:0001719) | 2.14208118 |
| 64 | Congenital malformation of the right heart (HP:0011723) | 2.14208118 |
| 65 | Myoglobinuria (HP:0002913) | 2.11093426 |
| 66 | Nephronophthisis (HP:0000090) | 2.10913754 |
| 67 | Abnormality of the axillary hair (HP:0100134) | 2.10191557 |
| 68 | Abnormality of secondary sexual hair (HP:0009888) | 2.10191557 |
| 69 | Rhabdomyolysis (HP:0003201) | 2.08424155 |
| 70 | Atrioventricular block (HP:0001678) | 2.07521955 |
| 71 | Type II lissencephaly (HP:0007260) | 2.07475476 |
| 72 | Intrahepatic cholestasis (HP:0001406) | 2.06250987 |
| 73 | Abnormality of the neuromuscular junction (HP:0003398) | 2.05728880 |
| 74 | Fatigable weakness (HP:0003473) | 2.05728880 |
| 75 | Neck muscle weakness (HP:0000467) | 2.04983789 |
| 76 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.01049874 |
| 77 | Subaortic stenosis (HP:0001682) | 2.01049874 |
| 78 | Left ventricular hypertrophy (HP:0001712) | 1.99190206 |
| 79 | Pancreatic fibrosis (HP:0100732) | 1.98242258 |
| 80 | Dilated cardiomyopathy (HP:0001644) | 1.96684335 |
| 81 | Abnormality of the renal medulla (HP:0100957) | 1.96097213 |
| 82 | Chronic hepatic failure (HP:0100626) | 1.95993637 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95838436 |
| 84 | Dysmetric saccades (HP:0000641) | 1.95450289 |
| 85 | Prolonged partial thromboplastin time (HP:0003645) | 1.94917219 |
| 86 | Hyperlipoproteinemia (HP:0010980) | 1.94807077 |
| 87 | Hypobetalipoproteinemia (HP:0003563) | 1.93184556 |
| 88 | Decreased circulating renin level (HP:0003351) | 1.90169791 |
| 89 | Abnormal finger flexion creases (HP:0006143) | 1.89981615 |
| 90 | Hypoalphalipoproteinemia (HP:0003233) | 1.88154133 |
| 91 | Muscle fiber splitting (HP:0003555) | 1.87840110 |
| 92 | Testicular atrophy (HP:0000029) | 1.86916712 |
| 93 | Hyperammonemia (HP:0001987) | 1.86756162 |
| 94 | Abnormality of midbrain morphology (HP:0002418) | 1.86077327 |
| 95 | Molar tooth sign on MRI (HP:0002419) | 1.86077327 |
| 96 | Hyperglycinuria (HP:0003108) | 1.85778238 |
| 97 | Malignant hyperthermia (HP:0002047) | 1.85455245 |
| 98 | Abnormality of glycine metabolism (HP:0010895) | 1.82433388 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82433388 |
| 100 | Absent eyebrow (HP:0002223) | 1.82132691 |
| 101 | Areflexia of lower limbs (HP:0002522) | 1.82104428 |
| 102 | True hermaphroditism (HP:0010459) | 1.81334600 |
| 103 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.80778773 |
| 104 | Abnormality of alanine metabolism (HP:0010916) | 1.80778773 |
| 105 | Hyperalaninemia (HP:0003348) | 1.80778773 |
| 106 | EMG: neuropathic changes (HP:0003445) | 1.79863237 |
| 107 | Clumsiness (HP:0002312) | 1.79472020 |
| 108 | Dysdiadochokinesis (HP:0002075) | 1.79313334 |
| 109 | Nonprogressive disorder (HP:0003680) | 1.79218220 |
| 110 | Fair hair (HP:0002286) | 1.79114658 |
| 111 | Broad-based gait (HP:0002136) | 1.78993639 |
| 112 | Hypolipoproteinemia (HP:0010981) | 1.78772715 |
| 113 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.78665316 |
| 114 | Short 1st metacarpal (HP:0010034) | 1.78665316 |
| 115 | Epidermoid cyst (HP:0200040) | 1.78041491 |
| 116 | Pheochromocytoma (HP:0002666) | 1.76510446 |
| 117 | Hamartoma of the eye (HP:0010568) | 1.75933839 |
| 118 | Amelogenesis imperfecta (HP:0000705) | 1.75678605 |
| 119 | Ulnar deviation of the wrist (HP:0003049) | 1.74870995 |
| 120 | Myotonia (HP:0002486) | 1.74572946 |
| 121 | Abnormality of the parathyroid morphology (HP:0011766) | 1.73883932 |
| 122 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.71515167 |
| 123 | Tubular atrophy (HP:0000092) | 1.71195380 |
| 124 | Status epilepticus (HP:0002133) | 1.71085342 |
| 125 | Abnormality of potassium homeostasis (HP:0011042) | 1.70064173 |
| 126 | Xanthomatosis (HP:0000991) | 1.68993401 |
| 127 | Amblyopia (HP:0000646) | 1.68307061 |
| 128 | Depressed nasal tip (HP:0000437) | 1.67874911 |
| 129 | Genetic anticipation (HP:0003743) | 1.67820356 |
| 130 | Mitochondrial inheritance (HP:0001427) | 1.67700536 |
| 131 | Anxiety (HP:0000739) | 1.67447472 |
| 132 | Bradycardia (HP:0001662) | 1.66316991 |
| 133 | Round ear (HP:0100830) | 1.66271500 |
| 134 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.66226459 |
| 135 | Proximal amyotrophy (HP:0007126) | 1.64656569 |
| 136 | Ragged-red muscle fibers (HP:0003200) | 1.64579760 |
| 137 | Metabolic acidosis (HP:0001942) | 1.64559046 |
| 138 | Limb dystonia (HP:0002451) | 1.64538583 |
| 139 | Renal cortical cysts (HP:0000803) | 1.63893760 |
| 140 | Conjugated hyperbilirubinemia (HP:0002908) | 1.63352478 |
| 141 | Azoospermia (HP:0000027) | 1.62860120 |
| 142 | Generalized myoclonic seizures (HP:0002123) | 1.62151880 |
| 143 | Epileptiform EEG discharges (HP:0011182) | 1.61911614 |
| 144 | Cystic liver disease (HP:0006706) | 1.61909200 |
| 145 | Muscular dystrophy (HP:0003560) | 1.61075329 |
| 146 | Large for gestational age (HP:0001520) | 1.60824064 |
| 147 | Abnormality of the labia majora (HP:0012881) | 1.59964073 |
| 148 | Difficulty running (HP:0009046) | 1.58669723 |
| 149 | Furrowed tongue (HP:0000221) | 1.58608927 |
| 150 | Progressive inability to walk (HP:0002505) | 1.58456366 |
| 151 | Drooling (HP:0002307) | 1.58359710 |
| 152 | Excessive salivation (HP:0003781) | 1.58359710 |
| 153 | Rimmed vacuoles (HP:0003805) | 1.58353663 |
| 154 | Curly hair (HP:0002212) | 1.57995895 |
| 155 | Enlarged kidneys (HP:0000105) | 1.57785631 |
| 156 | Gaze-evoked nystagmus (HP:0000640) | 1.57534093 |
| 157 | Abnormal pancreas size (HP:0012094) | 1.57147033 |
| 158 | Distal lower limb muscle weakness (HP:0009053) | 1.56334604 |
| 159 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.55812918 |
| 160 | Absent/shortened dynein arms (HP:0200106) | 1.55812918 |
| 161 | Protruding tongue (HP:0010808) | 1.53452198 |
| 162 | Bulbar palsy (HP:0001283) | 1.52918225 |
| 163 | Medial flaring of the eyebrow (HP:0010747) | 1.51653027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.42583004 |
| 2 | OBSCN | 3.32507909 |
| 3 | NTRK3 | 2.78575606 |
| 4 | PHKG1 | 2.75758352 |
| 5 | PHKG2 | 2.75758352 |
| 6 | MAP3K4 | 2.50819992 |
| 7 | MARK1 | 2.49327288 |
| 8 | CAMK1D | 2.34419987 |
| 9 | CAMK1G | 2.34284015 |
| 10 | MAP3K9 | 2.28588712 |
| 11 | CASK | 2.26784087 |
| 12 | MAP2K7 | 2.24594575 |
| 13 | MAP2K4 | 2.22248905 |
| 14 | DAPK2 | 2.05139287 |
| 15 | BMPR1B | 1.99730452 |
| 16 | LMTK2 | 1.88959581 |
| 17 | BCKDK | 1.88551280 |
| 18 | STK24 | 1.83269633 |
| 19 | MINK1 | 1.80949085 |
| 20 | ADRBK2 | 1.64510832 |
| 21 | ACVR1B | 1.62648016 |
| 22 | GRK1 | 1.56863528 |
| 23 | EEF2K | 1.54767541 |
| 24 | STK38L | 1.44711507 |
| 25 | NTRK2 | 1.43605056 |
| 26 | FER | 1.42056270 |
| 27 | PAK3 | 1.41997593 |
| 28 | MAPK13 | 1.41727772 |
| 29 | TNK2 | 1.33612818 |
| 30 | WNK4 | 1.30267380 |
| 31 | DMPK | 1.28526461 |
| 32 | CAMK2A | 1.28054309 |
| 33 | PLK2 | 1.26797256 |
| 34 | GRK5 | 1.21783280 |
| 35 | STK38 | 1.21068329 |
| 36 | FGFR2 | 1.18174818 |
| 37 | PIK3CG | 1.15468270 |
| 38 | CAMK2D | 1.13997502 |
| 39 | ERBB3 | 1.12407649 |
| 40 | PAK6 | 1.10296010 |
| 41 | PRKCG | 1.09817461 |
| 42 | PINK1 | 1.07420535 |
| 43 | KSR1 | 1.06459430 |
| 44 | LATS2 | 1.06297449 |
| 45 | MYLK | 1.05728738 |
| 46 | FRK | 1.04731586 |
| 47 | CAMK2B | 1.03462004 |
| 48 | MAPKAPK3 | 1.03252929 |
| 49 | MAP3K7 | 1.02959820 |
| 50 | PNCK | 1.00316127 |
| 51 | PIK3CA | 0.99159114 |
| 52 | PKN2 | 0.98391704 |
| 53 | NME1 | 0.98103548 |
| 54 | MUSK | 0.96707537 |
| 55 | CDK5 | 0.95977613 |
| 56 | PDK3 | 0.95303439 |
| 57 | PDK4 | 0.95303439 |
| 58 | TAOK3 | 0.94629331 |
| 59 | BMPR2 | 0.93689632 |
| 60 | SGK2 | 0.93329846 |
| 61 | KSR2 | 0.92791870 |
| 62 | TRPM7 | 0.92635401 |
| 63 | DYRK1A | 0.88863683 |
| 64 | SIK2 | 0.87245322 |
| 65 | AKT3 | 0.86803524 |
| 66 | CAMK2G | 0.85600655 |
| 67 | MAP3K2 | 0.83688009 |
| 68 | INSRR | 0.82997444 |
| 69 | SGK494 | 0.82140685 |
| 70 | SGK223 | 0.82140685 |
| 71 | ARAF | 0.81142037 |
| 72 | MAP3K12 | 0.78772320 |
| 73 | OXSR1 | 0.77303731 |
| 74 | PRPF4B | 0.76744108 |
| 75 | CAMKK1 | 0.75712360 |
| 76 | PRKCE | 0.73850164 |
| 77 | MAPK12 | 0.73373736 |
| 78 | CSNK1G2 | 0.72324643 |
| 79 | TTN | 0.71197119 |
| 80 | RIPK4 | 0.70319993 |
| 81 | EPHB2 | 0.70262181 |
| 82 | MAPK15 | 0.70171402 |
| 83 | GRK7 | 0.69257162 |
| 84 | CAMK1 | 0.69023081 |
| 85 | NEK1 | 0.68851632 |
| 86 | TNIK | 0.68694777 |
| 87 | MAP2K1 | 0.67651620 |
| 88 | TLK1 | 0.66677325 |
| 89 | PRKCZ | 0.64493090 |
| 90 | PRKCI | 0.64481781 |
| 91 | PKN1 | 0.63944317 |
| 92 | CSNK1G1 | 0.63155196 |
| 93 | NTRK1 | 0.63062265 |
| 94 | STK11 | 0.62592025 |
| 95 | PRKD3 | 0.61868438 |
| 96 | NUAK1 | 0.61690129 |
| 97 | CDC42BPA | 0.61321393 |
| 98 | MAP3K5 | 0.60607012 |
| 99 | MAP4K2 | 0.60257116 |
| 100 | BRAF | 0.59516142 |
| 101 | PTK2B | 0.59312982 |
| 102 | DAPK1 | 0.59244199 |
| 103 | CAMK4 | 0.59068678 |
| 104 | SGK1 | 0.58677946 |
| 105 | RPS6KB1 | 0.56876092 |
| 106 | TAOK1 | 0.55922231 |
| 107 | SGK3 | 0.55788809 |
| 108 | NLK | 0.55671696 |
| 109 | PRKAA2 | 0.55409793 |
| 110 | ROCK1 | 0.55264978 |
| 111 | LATS1 | 0.53449652 |
| 112 | CSNK1A1L | 0.53428470 |
| 113 | RET | 0.53087421 |
| 114 | TRIB3 | 0.52935120 |
| 115 | PRKAA1 | 0.52637115 |
| 116 | CSNK1G3 | 0.52029523 |
| 117 | BCR | 0.51059828 |
| 118 | STK39 | 0.49991711 |
| 119 | ILK | 0.49905378 |
| 120 | MARK2 | 0.49776080 |
| 121 | PRKACA | 0.49412382 |
| 122 | MAP2K6 | 0.48737831 |
| 123 | AKT2 | 0.48504055 |
| 124 | RIPK1 | 0.47473452 |
| 125 | ERBB4 | 0.46644004 |
| 126 | RPS6KA2 | 0.45407821 |
| 127 | PRKG1 | 0.45352123 |
| 128 | MAP3K6 | 0.45280311 |
| 129 | ADRBK1 | 0.44941534 |
| 130 | WNK3 | 0.44920471 |
| 131 | CSNK1D | 0.43277719 |
| 132 | MKNK2 | 0.42024875 |
| 133 | MTOR | 0.40232036 |
| 134 | TRIM28 | 0.36825315 |
| 135 | STK3 | 0.34982487 |
| 136 | WNK1 | 0.34386104 |
| 137 | TGFBR1 | 0.34276659 |
| 138 | RPS6KA3 | 0.34197517 |
| 139 | MARK3 | 0.31685919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.91444673 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 2.29662036 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19214009 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.18384584 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.13459936 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.06955848 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.93611871 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77886656 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.76431427 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.75674910 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.74099478 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74061612 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.64162953 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64108203 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62593302 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61986930 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.61721077 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.58797338 |
| 19 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.58643599 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54147070 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53748385 |
| 22 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.52640153 |
| 23 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51158486 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.47744910 |
| 25 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.46823398 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.44260264 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42433189 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.42232315 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.39035719 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.38623844 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38390210 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.38238538 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37427330 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.37298306 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34599433 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.34302968 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.33968708 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32343759 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.30942739 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25484296 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22204504 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20028018 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.19546519 |
| 44 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18979898 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18596026 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16593919 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.15824337 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15704427 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.15291701 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09849808 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.08916867 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08680780 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07892406 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 1.07880314 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07411005 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05501881 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04506340 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.02659021 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02417929 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01927761 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01790101 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01558304 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00890057 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.99013631 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95426221 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95251579 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94719247 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94639024 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94466683 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92395650 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91635276 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.91124781 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89889809 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85925130 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84384173 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84069109 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83249427 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81915625 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79828275 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78946773 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.75254787 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.74895959 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.74476721 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72546896 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72369117 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.71831294 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71688050 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.70531767 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70482102 |
| 90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70367266 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68894490 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68546348 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67401222 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66969246 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66856157 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65832273 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65771071 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65681340 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.63782671 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63646394 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63324825 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62180985 |
| 103 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61306533 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60838220 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59706216 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57876084 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56280580 |
| 108 | Gap junction_Homo sapiens_hsa04540 | 0.55725304 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54712116 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54666930 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54589707 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52952152 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52635986 |
| 114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52503531 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51493745 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51492207 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51096469 |
| 118 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49173963 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49065833 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47773870 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46654846 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45192330 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44294929 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.43595242 |
| 125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42556927 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42481334 |

